EmbraceRX Review
Best for: Shoppers wanting compounded GLP-1 plus a deep peptide and longevity menu, prescribed online
EmbraceRX (Embrace Rx) is a clinician-guided telehealth platform offering pharmacy-compounded medications prescribed online, partnered with the Samaritan MD physician network. Its weight-loss menu spans compounded semaglutide (+B12), tirzepatide, oral GLP-1 capsules, Lipo-B, and investigational options like retatrutide and AOD-9604, plus a large peptide/longevity catalog and hormone, sexual-health, and hair care. Medications are compounded at FDA-registered pharmacies; pricing shows only at checkout, and no LegitScript certification is displayed.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
EmbraceRX is a solid telehealth option with balanced features and pricing.
EmbraceRX at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Retatrutide
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored EmbraceRX
Each dimension is scored algorithmically from EmbraceRX’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.4/10EmbraceRX does not post a standard monthly cash price up front, so cost transparency is limited — confirm the ongoing rate before you commit.
Effectiveness25%
8.3/10EmbraceRX offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.5/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.4/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-23).
Accessibility10%
6.2/10EmbraceRX's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.0/10EmbraceRX provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this EmbraceRX review
Last checked 2026-06-23- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications EmbraceRX offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
What we like
- Broad compounded GLP-1 menu — semaglutide (+B12), tirzepatide, oral semaglutide/tirzepatide capsules, plus Lipo-B
- Large peptide/longevity catalog (BPC-157, GHK-Cu, NAD+, MOTS-C) across injectable, oral, topical, and nasal formats
- Clinician-guided, compounded at FDA-registered pharmacies; partners with a licensed physician network (Samaritan MD)
- Full legal suite published (Terms, Privacy, HIPAA Notice, CCPA, Returns & Refunds)
Watch-outs
- Pricing not shown upfront — revealed only at checkout after a dose selection
- Offers investigational/research compounds (e.g., retatrutide, AOD-9604) that are not FDA-approved
- Compounding pharmacy partner not named ('FDA-registered pharmacies')
- Not LegitScript-certified (no certification displayed)
Is EmbraceRX worth it? Our verdict
EmbraceRX positions itself around one thing: Shoppers wanting compounded GLP-1 plus a deep peptide and longevity menu, prescribed online. Its standout is a needle-free oral option, which very few providers offer.
How much EmbraceRX actually costs
EmbraceRX doesn't post a standard monthly cash price publicly. Start a consultation to get an exact quote, and confirm the ongoing rate — not just any first-month offer — before you commit.
Medications: what EmbraceRX prescribes
EmbraceRX prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes.
EmbraceRX's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who EmbraceRX is best for — and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. We explain how we weigh medical oversight and compliance in our scoring methodology.
Bottom line
EmbraceRX could be worth a look, but it doesn't publish a standard price up front — get a quote and confirm the ongoing rate before deciding, and compare it against the alternatives below.
Ready to start with EmbraceRX?
See current pricing and start your free consultation.
Alternatives to EmbraceRX
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this EmbraceRX review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Ready to start with EmbraceRX?
See current pricing and start your free consultation.